NVDA:NASDAQNVIDIA Corporation Analysis
Data as of 2026-03-09 - not real-time
$177.89
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
NVIDIA’s stock is trading just above its long‑term average but has slipped beneath its short‑term moving averages, with momentum indicators turning bearish and the RSI hovering in neutral territory. Volume is accelerating and the price remains comfortably above the identified support level, while volatility and beta remain elevated, underscoring heightened price swings.
Fundamentally, the company is delivering exceptional profitability margins and a striking revenue acceleration, and analysts are collectively forecasting a substantial upside toward the mid‑$260 price range. The imminent first dividend of the year and a strong cash position further bolster the outlook, though recent news of halted chip shipments to China adds a layer of regulatory uncertainty.
Fundamentally, the company is delivering exceptional profitability margins and a striking revenue acceleration, and analysts are collectively forecasting a substantial upside toward the mid‑$260 price range. The imminent first dividend of the year and a strong cash position further bolster the outlook, though recent news of halted chip shipments to China adds a layer of regulatory uncertainty.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD divergence and price below short‑term averages
- Elevated volatility and beta signaling rapid moves
- Support level providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust revenue acceleration and expanding profit margins
- Analyst consensus target near $265 indicating sizable upside
- Increasing trading volume reflecting strong investor interest
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Leadership in AI‑driven data‑center and graphics markets
- Sustainable cash flow supporting low‑payout dividend and reinvestment
- Long‑term growth narrative tied to AI, cloud and automotive ecosystems
Key Metrics & Analysis
Financial Health
Revenue Growth73.20%
Profit Margin55.60%
P/E Ratio36.2
ROE101.48%
ROA51.19%
Debt/Equity7.25
P/B Ratio27.5
Op. Cash Flow$102.7B
Free Cash Flow$58.1B
Industry P/E36.2
Technical Analysis
TrendBullish
RSI42.4
Support$174.60
Resistance$197.63
MA 20$186.16
MA 50$186.01
MA 200$176.14
MACDBearish
VolumeIncreasing
Fear & Greed Index68.77
Valuation
Fair Value$93.31
Target Price$265.18
Upside/Downside49.08%
GradeOvervalued
TypeGrowth
Dividend Yield0.02%
Risk Assessment
Beta1.70
Volatility40.66%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.